About this trial
This study is a randomized controlled trial designed to evaluate the effectiveness of a semi-autonomous upper-limb rehabilitation program based on exergames in adults with chronic stroke. Participants will be randomly assigned (1:1) to either an exergame-based intervention or an individually delivered conventional home-based therapy program. The primary outcome is upper-limb functionality as measured by the Action Research Arm Test (ARAT). Secondary outcomes include upper-limb motor function and quality of life. The study also examines adherence, usability, and the feasibility of remote monitoring for long-term implementation.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Confirmed diagnosis of chronic stroke with more than 6 months of evolution.
Ability to maintain independent sitting and standing (with or without assistive devices).
Upper-limb functional capacity ranging from limited to moderate, defined as an ARAT score between 11 and 54 points.
Disqualifiers
Acute illness, musculoskeletal pathology, or pain that interferes with the performance of rehabilitation exercises.
Uncompensated sensory deficits, including significant visual or hearing impairments.
Disruptive behavior or neuropsychiatric conditions that may limit participation.
Active epilepsy or any medical contraindication to physical exercise.
Trial design
Treatments tested in this trial
- Exergame-Based Upper-Limb Training
- Conventional Individual Rehabilitation
Treatment groups
Locations
Sponsors and collaborators
Marina Castel Sánchez
Lead sponsor
European University of Madrid
Sponsor institution